Cloud-clone
SKU:MAA045Ca21
Monoclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)
Monoclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF)
Couldn't load pickup availability
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
Product No.
MAA045Ca21
Organism Species
Canis familiaris; Canine (Dog).
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
n/a
Ig Isotype
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
1mg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against GM-CSF. It has been selected for its ability to recognize GM-CSF in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:500-5000
Immunohistochemistry: 5-20µg/mL;1:50-200
Immunocytochemistry: 5-20µg/mL;1:50-200
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Journal of Toxicology and Environmental Health | Effects of 900-MHz Microwave Radiation on γ-Ray-Induced Damage to Mouse Hematopoietic System PubMed: 20391130 |
| 5 | Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial Pubmed:24525316 |
| Archives of Virology | Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China Pubmed:29305646 |
| BioMed Research International | Activated Macrophages of Monocytic Origin Predominantly Express Proinflammatory Cytokine Genes, Whereas Kupffer Cells Predominantly Express Anti … |
| bulletin of experimental biology and medicine | Quantitative and Qualitative Characterization of Phagocytic Activity of Macrophages of Bone Marrow and Fetal Origin Pubmed: 31183654 |
| Exp Mol Pathol | The regulatory role of SFRP5/WNT5A axis in allergic rhinitis through inhibiting JNK pathway activation and lowering mucin generation in human nasal?¡ 33285209 |
| Vaccine | Co-delivery of PSMA antigen epitope and mGM-CSF with a cholera toxin-like chimeric protein suppressed prostate tumor growth via activating dendritic cells and?¡ 33612342 |
| Catalog No. | Related products for research use of Canis familiaris; Canine (Dog) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA045Ca01 | Recombinant Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA045Ca01 | Polyclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) | WB; IHC; ICC; IP. |
| MAA045Ca21 | Monoclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) | WB; IHC; ICC; IP. |
| SEA045Ca | ELISA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA045Ca | CLIA Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA045Ca | Magnetic Luminex Assay Kit for Colony Stimulating Factor 2, Granulocyte Macrophage (GM-CSF) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
